Skip to main content

Table 3 Analysis of the risk factors of neonatal hypoglycemia in all cases (n = 603)

From: Incidence and risk factors of neonatal hypoglycemia after ritodrine therapy in premature labor: a retrospective cohort study

  No Neonatal Hypoglycemia Neonatal Hypoglycemia p value AOR 95%CI p value
Case (n) 504 (83.6) 99 (16.4)     
Gestational age (wk/day) 38/5 (36/0 – 41/6) 37/1 (36/0 – 41/2) < 0.001 0.516 0.366–0.726 < 0.001
Birth weight < 2500 g (n) 57 (11.3) 47 (47.5) < 0.001 3.484 1.856–6.540 < 0.001
Twin birth (n) 24 (4.8) 30 (30.3) < 0.001 1.645 0.772–3.505 0.197
Maternal diabetes (n) 21 (4.2) 5 (5.1) 0.598 1.272 0.358–4.521 0.710
Oral administration of RD (n) 68 (13.5) 17 (17.2) 0.344 0.806 0.393–1.654 0.557
Intravenous administration of RD (n) 36 (7.1) 58 (58.6) < 0.001 6.595 3.307–13.153 < 0.001
  1. Data are expressed as median (min-max) or number (%)
  2. RD Ritodrine hydrochloride, AOR Adjusted odds ratio, CI Confidence interval